< Arab Finance - News - Rameda okays stocks dividends
Count Down to relaunch

Rameda okays stocks dividends

Rameda okays stocks dividends

ArabFinance: Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents’ (Rameda) (RMDA) ordinary general assembly approved stock dividends for 2020, according to the company statement filed to the Egyptian Exchange.

Financed from 2020’s profit, Rameda will distribute 0.30 free share for everyone held with a total amount of EGP 57.8 million.

Accordingly, the issued and paid-in capital will be increased to EGP 250 million distributed on one billion shares at par value of EGP 0.25 per each.

The listed company reported a 36% Year on Year increase in its consolidated net profit in 2020, recording EGP 112.18 million.

Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals. It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others.

#Related keywords


Recommended Stocks

13 Jun 2022
Delta Sugar SUGR

All rights reserved to Arab Finance 2020 ©

Back to top